Literature DB >> 30023009

Improving drug adherence in osteoporosis: an update on more recent studies.

Ayesha Jaleel1, Kenneth G Saag2, Maria I Danila3.   

Abstract

Similar to other chronic diseases such as diabetes and hypertension, osteoporosis has struggled with suboptimal medication adherence, resulting in an increased risk of fractures and all-cause mortality. The goal of this narrative review was to summarize interventions to improve medication adherence in osteoporosis. Because past reviews of this topic covered published literature through 2013, we conducted our literature search to include the period between January 2012 and November 2017. We identified 10 studies evaluating healthcare system and patient interventions aimed at improving osteoporosis treatment adherence, including three fracture liaison service (FLS) programs, one pharmacist-delivered counseling program, and six patient-directed interventions consisting of three coaching or counseling programs and three interventions using reminder prompts. Four out of the six patient-directed interventions did not lead to significant improvements in outcomes, suggesting that patient-directed interventions may have limited success in this setting. The healthcare system interventions that evaluated FLS programs and pharmacist-directed tailored counseling were effective at improving medication adherence; however, the studies were not randomized, they were costly, resource intensive and effective in countries with more centralized healthcare, possibly limiting their generalizability. In conclusion, while healthcare system interventions such as FLS, and pharmacist-delivered counseling appeared to be successful in improving osteoporosis medication adherence in some settings, behavioral interventions including patient counseling and reminder prompts for medication utilization were not, perhaps due to patient perceptions regarding osteoporosis consequences and need for treatment. Thus, these patient attributes may define patients 'at high risk' for poor adherence and developing intervention approaches to enhance patient knowledge and understanding of osteoporosis and its consequences may improve the perception of the need for treatment, optimize osteoporosis care and thereby improve overall outcomes of patients with osteoporosis. We hope that the knowledge gained through our review will help inform the design of further programs aimed at optimizing osteoporosis care.

Entities:  

Keywords:  fracture liaison service; medication adherence; osteoporosis treatment interventions

Year:  2018        PMID: 30023009      PMCID: PMC6047244          DOI: 10.1177/1759720X18785539

Source DB:  PubMed          Journal:  Ther Adv Musculoskelet Dis        ISSN: 1759-720X            Impact factor:   5.346


  26 in total

1.  Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital's fracture liaison service between January 2010 and December 2011.

Authors:  N Dehamchia-Rehailia; D Ursu; I Henry-Desailly; P Fardellone; J Paccou
Journal:  Osteoporos Int       Date:  2014-07-01       Impact factor: 4.507

2.  Proactive pharmaceutical care interventions decrease patients' nonadherence to osteoporosis medication.

Authors:  A G G Stuurman-Bieze; E G Hiddink; J F M van Boven; S Vegter
Journal:  Osteoporos Int       Date:  2014-02-26       Impact factor: 4.507

3.  Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.

Authors:  P S M Lai; S S Chua; Y Y Chew; S P Chan
Journal:  J Clin Pharm Ther       Date:  2010-10-26       Impact factor: 2.512

4.  Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.

Authors:  Ethel S Siris; Steven T Harris; Clifford J Rosen; Charles E Barr; James N Arvesen; Thomas A Abbott; Stuart Silverman
Journal:  Mayo Clin Proc       Date:  2006-08       Impact factor: 7.616

5.  Improving adherence to and persistence with oral therapy of osteoporosis.

Authors:  M L Bianchi; P Duca; S Vai; G Guglielmi; R Viti; C Battista; A Scillitani; S Muscarella; G Luisetto; V Camozzi; R Nuti; C Caffarelli; S Gonnelli; C Albanese; V De Tullio; G Isaia; P D'Amelio; F Broggi; M Croci
Journal:  Osteoporos Int       Date:  2015-01-27       Impact factor: 4.507

6.  Adherence with bisphosphonate therapy and change in bone mineral density among women with osteoporosis or osteopenia in clinical practice.

Authors:  D Weycker; L Lamerato; S Schooley; D Macarios; T Siu Woodworth; N Yurgin; G Oster
Journal:  Osteoporos Int       Date:  2012-08-18       Impact factor: 4.507

7.  The role of counselling and other factors in compliance of postmenopausal osteoporotic patients to alendronate 70 therapy.

Authors:  Ewa Sewerynek; Hanna Horst-Sikorska; Wioletta Stępień-Kłos; Agnieszka Antkowiak; Małgorzata Janik; Karol Cieślak; Michalina Marcinkowska; Agnieszka Cegłowska; Michał Stuss
Journal:  Arch Med Sci       Date:  2013-04-22       Impact factor: 3.318

8.  Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle.

Authors:  K Akesson; D Marsh; P J Mitchell; A R McLellan; J Stenmark; D D Pierroz; C Kyer; C Cooper
Journal:  Osteoporos Int       Date:  2013-04-16       Impact factor: 4.507

9.  Impact of the training on the compliance and persistence of weekly bisphosphonate treatment in postmenopausal osteoporosis: a randomized controlled study.

Authors:  Şansın Tüzün; Gülseren Akyüz; Nurten Eskiyurt; Asuman Memiş; Banu Kuran; Afitap İçağasıoğlu; Tunay Sarpel; Ferda Özdemir; Neşe Özgirgin; Rezzan Günaydın; Aytül Cakçı; Merih Yurtkuran
Journal:  Int J Med Sci       Date:  2013-11-20       Impact factor: 3.738

10.  Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis?

Authors:  Jae-Hwi Nho; Young-Kyun Lee; Yong-Chan Ha; Chung-Hyun Kim; You-Sung Suh; Kyung-Hoi Koo
Journal:  J Bone Metab       Date:  2016-05-31
View more
  8 in total

1.  Long-term compliance of patients with osteoporosis treatment and its effect to fracture occurrence.

Authors:  Róbert Čellár; Erik Dorko; Kvetoslava Rimárová; Matúš Bereš; David Sokol; Ahmad Gharaibeh; Martin Folvarský; István Mitró; Viliam Knap
Journal:  Cent Eur J Public Health       Date:  2022-06       Impact factor: 1.154

2.  Understanding Physicians' Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach.

Authors:  Haiyan Qu; Stuart L Silverman; Richard M Shewchuk; Jeffrey R Curtis; Shamly Austin; Susan L Greenspan; Jeri W Nieves; Ryan C Outman; Amy H Warriner; Nelson B Watts; Kenneth G Saag
Journal:  Risk Manag Healthc Policy       Date:  2022-07-05

3.  Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment.

Authors:  G Adami; K G Saag; A S Mudano; E J Rahn; N C Wright; R C Outman; S L Greenspan; A Z LaCroix; J W Nieves; S L Silverman; E S Siris; N B Watts; M J Miller; S Ladores; J R Curtis; M I Danila
Journal:  Osteoporos Int       Date:  2020-02-04       Impact factor: 4.507

4.  Effects of the falls and fractures clinic as an integrated multidisciplinary model of care in Australia: a pre-post study.

Authors:  Fernando Gomez; Carmen Lucia Curcio; Sharon Lee Brennan-Olsen; Derek Boersma; Steven Phu; Sara Vogrin; Pushpa Suriyaarachchi; Gustavo Duque
Journal:  BMJ Open       Date:  2019-07-29       Impact factor: 2.692

5.  Krüppel-like factor 3 inhibition by mutated lncRNA Reg1cp results in human high bone mass syndrome.

Authors:  Mi Yang; Qi Guo; Hui Peng; Yu-Zhong Xiao; Ye Xiao; Yan Huang; Chang-Jun Li; Tian Su; Yun-Lin Zhang; Min-Xiang Lei; Hui-Ling Chen; Tie-Jian Jiang; Xiang-Hang Luo
Journal:  J Exp Med       Date:  2019-06-13       Impact factor: 14.307

6.  Predictors and Outcomes Associated With Adherence to Weekly Alendronate in US Military Veterans: Clinical Research Study.

Authors:  Sarah Bou Malham; Benjamin Bowe; Sumon K Sen; Rong Mei Zhang; Barbara Sterkel; Julia P Dunn
Journal:  J Prim Care Community Health       Date:  2019 Jan-Dec

7.  Improvement of osteoporosis Care Organized by Nurses: ICON study - Protocol of a quasi-experimental study to assess the (cost)-effectiveness of combining a decision aid with motivational interviewing for improving medication persistence in patients with a recent fracture being treated at the fracture liaison service.

Authors:  Dennis Cornelissen; Annelies Boonen; Silvia Evers; Joop P van den Bergh; Sandrine Bours; Caroline E Wyers; Sander van Kuijk; Marsha van Oostwaard; Trudy van der Weijden; Mickaël Hiligsmann
Journal:  BMC Musculoskelet Disord       Date:  2021-10-29       Impact factor: 2.362

8.  Osteoporosis in 10 years time: a glimpse into the future of osteoporosis.

Authors:  Giovanni Adami; Angelo Fassio; Davide Gatti; Ombretta Viapiana; Camilla Benini; Maria I Danila; Kenneth G Saag; Maurizio Rossini
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-03-20       Impact factor: 5.346

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.